How Much Does Immunotherapy for breast cancer Cost in Thailand in AUD?
Immunotherapy for breast cancer in Thailand costs from AUD $8,900 / ฿200,600 to AUD $21,100 / ฿476,000 on average. Final expenses depend on the specific drug protocol, patient weight, and hospital tier. Costs usually include specialist consultations, drug administration, and basic follow-up care.
- Targeted protocol: Typically runs 20–30% higher when using specific drugs like pembrolizumab.
- Hospital tier: Private JCI-accredited centres in Bangkok often charge 30–40% more than regional clinics.
- Diagnostic testing: Pre-treatment PD-L1 analysis or PET scans can add approximately A$3,800 to the budget.
- Ancillary therapies: Integrative programmes including oncothermia or ozone therapy can significantly increase the total price.
Bookimed Expert Insight: Choosing a major hub like Bangkok provides access to some of the world's most technologically advanced clinics. Bumrungrad International Hospital is a prime example. It is ranked among the top 10 hospitals globally and is accredited by Joint Commission International (JCI). This scale allows for efficient coordination of complex oncology treatments for international patients. While premium hospitals charge more, their high volume and multidisciplinary teams often provide better value for complex cases.
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for breast cancer upon arrival and use a flexible instalment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for breast cancer and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for breast cancer journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Immunotherapy for breast cancer Clinics in Thailand for Australians: 2 Verified Options and AUD Prices
Panacee Medical Center – Stem Cell & Cell Therapy Center
Immunotherapy for breast cancer Overview in Thailand
- Immunotherapy - from AUD $8,911This therapy boosts the body"s natural defenses to fight diseases like cancer, bringing less side effects.
- Immunotherapy for prostate cancer - from AUD $8,911This therapy boosts the body"s immune system to fight against prostate cancer, offering a targeted, typically well-tolerated treatment.
- Immunotherapy for lung cancer - from AUD $8,911This therapy boosts your body"s natural defenses to fight lung cancer, using substances made by the body itself.
- Immunotherapy for breast cancer - from AUD $8,911This therapy boosts your immune system to fight and eradicate breast cancer cells effectively.
- Immunotherapy for kidney cancer - from AUD $8,911This therapy boosts the body"s natural defenses, often prolonging life in kidney cancer patients.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Doctors
View all Doctors
Prakasit Chirappapha
The doctor is an oncosurgeon specializing in the treatment of breast cancer. With extensive experience in oncological surgery, the doctor focuses on innovative surgical techniques and personalized patient care. The doctor has contributed to numerous clinical trials and research studies aimed at improving breast cancer treatment outcomes. The doctor is affiliated with leading medical institutions and has presented findings at international conferences, highlighting advancements in minimally invasive procedures.
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
FAQ about Immunotherapy for breast cancer in Thailand
Which breast cancer types are eligible for immunotherapy in Thailand?
Immunotherapy in Thailand primarily targets triple-negative breast cancer (TNBC) and HER2-positive subtypes. Patient eligibility depends on clinical staging and protein expression levels like PD-L1. It also depends on the absence of autoimmune conditions. JCI-accredited facilities such as Bumrungrad International Hospital specialise in providing these drug protocols for international patients.
- Triple-negative breast cancer: Eligible cases include high-risk early-stage or metastatic tumours with PD-L1 markers.
- HER2-positive breast cancer: Patients receive passive immunotherapy using monoclonal antibodies like trastuzumab or pertuzumab.
- Diagnostic threshold testing: Advanced TNBC eligibility requires specific PD-L1 protein expression levels before treatment.
- Health exclusions: Active autoimmune diseases like lupus generally exclude patients from receiving immune checkpoint inhibitors.
Bookimed Expert Insight: Bumrungrad International Hospital serves over 1,000,000 patients annually. It also maintains Global Healthcare Accreditation for international services. This scale allows them to stock newer biosimilars like Herdara. These local options can help manage the costs of HER2-positive antibody maintenance therapy.
What is the typical treatment timeline and stay duration for immunotherapy for breast cancer in Thailand?
Immunotherapy for breast cancer in Thailand involves infusions every 3 to 6 weeks. The first visit takes 10–14 days for consultations, biomarker testing, and monitoring. Subsequent cycles last 5–7 days. Total treatment generally spans 6 months to 2 years depending on the cancer stage.
- Initial assessment: First trips take 10–14 days for oncology reviews and biomarker testing.
- Cycle frequency: Infusions like Pembrolizumab usually occur every 3 to 6 weeks.
- Subsequent stays: Return trips for outpatient infusions typically require 5–7 days in Bangkok.
- Relocation model: Some patients stay 3–6 months for combined chemotherapy and immunotherapy.
Bookimed Expert Insight: Major Bangkok centres like Bumrungrad International Hospital serve over 500,000 international patients annually. They offer telemedicine for follow-up care. Using these remote services allows Australian patients to monitor side effects from home. This reduces the time needed in Thailand for each cycle to just 5 days.
Patient Consensus: Patients suggest bringing full pathology reports and prior imaging. This speeds up the initial assessment in Thailand. Combining your treatment blocks with a medical visa allows for easier multiple entries over 12 months.
Which immunotherapy drugs are available in Thai hospitals for breast cancer treatment?
JCI-accredited hospitals in Bangkok provide approved immunotherapy drugs for breast cancer. These primarily target triple-negative and HER2-positive subtypes. Key treatments include immune checkpoint inhibitors like Pembrolizumab and Atezolizumab. Doctors also use HER2-targeted therapies such as Trastuzumab and antibody-drug conjugates like Enhertu.
- Checkpoint inhibitors: Pembrolizumab (Keytruda) treats high-risk early-stage or advanced triple-negative breast cancer.
- HER2-targeted agents: Trastuzumab (Herceptin) and Pertuzumab (Perjeta) are standard for HER2-positive cases.
- Conjugates: Kadcyla and Enhertu deliver chemotherapy directly to specific HER2-positive cancer cells.
- Diagnostic testing: Hospitals perform PD-L1 expression and MSI-H testing to confirm drug eligibility.
Bookimed Expert Insight: Thailand is one of the few medical hubs producing high-quality domestic biosimilars like Herdara. This makes standard HER2-positive therapy more accessible at major centres like Bumrungrad International Hospital. This facility handles over 1,000,000 patients annually. It also maintains Global Healthcare Accreditation for international surgical care.
Do Thai hospitals accommodate international medical tourists seeking breast cancer immunotherapy?
Thai hospitals accommodate many international medical tourists seeking breast cancer immunotherapy. Leading centres such as Bumrungrad International Hospital and Bangkok Hospital offer checkpoint inhibitors and molecular testing. These JCI-accredited facilities feature dedicated international wings and English-speaking specialist teams. They also provide streamlined medical visa support for Australian patients.
- Oncology units: Bumrungrad International Hospital treats patients from over 190 countries annually.
- Specialised cancer centres: Wattanosoth Cancer Hospital focuses exclusively on molecular and genetic profiling.
- International patient services: Dedicated teams manage airport transfers, medical translations, and visa extensions.
- Global quality standards: Top-tier facilities hold Global Healthcare Accreditation for international patient excellence.
Bookimed Expert Insight: Thai hospitals like Bumrungrad treat over 1,000,000 patients annually. Half of these are international visitors. This high volume means oncology teams have seen almost every breast cancer subtype. For Australians, this level of experience often exceeds what smaller private clinics offer at home.
Patient Consensus: Patients travelling to Thailand value the hospitality of dedicated international wings. They also appreciate the speed of starting immunotherapy. Many feel like a guest rather than just another patient during intensive treatments.










